{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:14:36Z","timestamp":1790554476976,"version":"4.1.0"},"reference-count":54,"publisher":"Impact Journals, LLC","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2020,11,8]]},"DOI":"10.18632\/aging.103962","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T09:26:12Z","timestamp":1604654772000},"page":"21660-21673","source":"Crossref","is-referenced-by-count":28,"title":["Human mesenchymal stem cells treatment improved hepatic lesions and reversed gut microbiome disorder in non-alcoholic steatohepatitis"],"prefix":"10.18632","volume":"12","author":[{"given":"Zhiyu","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Henan Provincial People\u2019s Hospital, People's Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou 450003, Henan, China"},{"name":"Microbiology Laboratory, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou 450003, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoyun","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Henan Provincial People\u2019s Hospital, People's Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou 450003, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Henan Provincial People\u2019s Hospital, People's Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou 450003, Henan, China"},{"name":"Microbiology Laboratory, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou 450003, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yue","sequence":"additional","affiliation":[{"name":"Stem Cell Research Center, Henan Key Laboratory of Stem Cell Differentiation and Modification Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou 450003, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Henan Provincial People\u2019s Hospital, People's Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou 450003, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalong","family":"Li","sequence":"additional","affiliation":[{"name":"Stem Cell Research Center, Henan Key Laboratory of Stem Cell Differentiation and Modification Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou 450003, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Henan Provincial People\u2019s Hospital, People's Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou 450003, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuling","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Henan Provincial People\u2019s Hospital, People's Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou 450003, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingbo","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Henan Provincial People\u2019s Hospital, People's Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou 450003, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2020,11,8]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.clinbiochem.2015.06.023","article-title":"Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.","volume":"4","author":"McClain","year":"2015","journal-title":"Clin Biochem"},{"key":"2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.bpg.2017.09.008","article-title":"NAFLD, helicobacter species and the intestinal microbiome.","volume":"3","author":"Kaakoush","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"3","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.3390\/ijms20215266","article-title":"The crosstalk of miRNA and oxidative stress in the liver: from physiology to pathology and clinical implications.","volume":"2","author":"Ocker","year":"2019","journal-title":"Int J Mol Sci"},{"key":"4","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/TP.0000000000000945","article-title":"Nonalcoholic steatohepatitis is the most rapidly growing indication for simultaneous liver kidney transplantation in the United States.","volume":"10","author":"Kuo","year":"2016","journal-title":"Transplantation"},{"key":"5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.","volume":"14","author":"Ahmed","year":"2015","journal-title":"Gastroenterology"},{"key":"6","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.transproceed.2010.02.013","article-title":"Liver transplantation: where we are and where we are heading.","volume":"4","author":"Esquivel","year":"2010","journal-title":"Transplant Proc"},{"key":"7","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.3390\/ijms21093066","article-title":"The molecular and mechanistic insights based on gut-liver axis: nutritional target for non-alcoholic fatty liver disease (NAFLD) improvement.","volume":"2","author":"Zhang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"8","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome.","volume":"14","author":"Van Hylckama Vlieg","year":"2012","journal-title":"Gastroenterology"},{"key":"9","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.3389\/fmicb.2018.01967","article-title":"Butyrate protects mice against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis by improving gut barrier function, attenuating inflammation and reducing endotoxin levels.","volume":"9","author":"Li","year":"2018","journal-title":"Front Microbiol"},{"key":"10","doi-asserted-by":"publisher","first-page":"6927","DOI":"10.1038\/s41598-017-07091-1","article-title":"Administration of lactobacillus salivarius LI01 or pediococcus pentosaceus LI05 prevents CCl-induced liver cirrhosis by protecting the intestinal barrier in rats.","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"key":"11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12989-019-0332-2","article-title":"Hepatotoxicity and the role of the gut-liver axis in rats after oral administration of titanium dioxide nanoparticles.","volume":"1","author":"Jia","year":"2019","journal-title":"Part Fibre Toxicol"},{"key":"12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nri.2017.7","article-title":"Dysbiosis and the immune system.","volume":"1","author":"Elinav","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.freeradbiomed.2016.11.037","article-title":"Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.","volume":"10","author":"S\u00e1nchez-Campos","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"14","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41598-017-01751-y","article-title":"Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota.","volume":"7","author":"Fan","year":"2017","journal-title":"Sci Rep"},{"key":"15","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.","volume":"6","author":"Diehl","year":"2016","journal-title":"Hepatology"},{"key":"16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000498946","article-title":"Gut microbiota profiles in nonalcoholic fatty liver disease and its possible impact on disease progression evaluated with transient elastography: lesson learnt from 60 cases.","volume":"1","author":"Gani","year":"2019","journal-title":"Case Rep Gastroenterol"},{"key":"17","doi-asserted-by":"publisher","first-page":"8628027","DOI":"10.1155\/2019\/8628027","article-title":"Human umbilical cord-derived mesenchymal stem cell therapy ameliorates nonalcoholic fatty liver disease in obese type 2 diabetic mice.","volume":"201","author":"Mu","year":"2019","journal-title":"Stem Cells Int"},{"key":"18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.intimp.2016.11.012","article-title":"Compact bone-derived mesenchymal stem cells attenuate nonalcoholic steatohepatitis in a mouse model by modulation of CD4 cells differentiation.","volume":"4","author":"Liu","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"19","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/jnr.24548","article-title":"Umbilical cord blood stem cell therapy in premature brain injury: opportunities and challenges.","volume":"9","author":"Wang","year":"2020","journal-title":"J Neurosci Res"},{"key":"20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00535-016-1258-1","article-title":"Status of and candidates for cell therapy in liver cirrhosis: overcoming the \u201cpoint of no return\u201d in advanced liver cirrhosis.","volume":"5","author":"Tsuchiya","year":"2017","journal-title":"J Gastroenterol"},{"key":"21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41232-017-0045-6","article-title":"Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases.","volume":"3","author":"Terai","year":"2017","journal-title":"Inflamm Regen"},{"key":"22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/sctm.18-0105","article-title":"Mesenchymal stem cells and induced bone marrow-derived macrophages synergistically improve liver fibrosis in mice.","volume":"8","author":"Terai","year":"2019","journal-title":"Stem Cells Transl Med"},{"key":"23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1440-1746.2011.07024.x","article-title":"Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients.","volume":"2","author":"Wang","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"24","doi-asserted-by":"publisher","first-page":"3212643","DOI":"10.1155\/2018\/3212643","article-title":"Extracellular vesicles from amnion-derived mesenchymal stem cells ameliorate hepatic inflammation and fibrosis in rats.","volume":"201","author":"Sakamoto","year":"2018","journal-title":"Stem Cells Int"},{"key":"25","doi-asserted-by":"publisher","first-page":"5924983","DOI":"10.1155\/2020\/5924983","article-title":"A small-sized population of human umbilical cord blood-derived mesenchymal stem cells shows high stemness properties and therapeutic benefit.","volume":"202","author":"Jin","year":"2020","journal-title":"Stem Cells Int"},{"key":"26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement.","volume":"8","author":"Horwitz","year":"2006","journal-title":"Cytotherapy"},{"key":"27","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease.","volume":"4","author":"Sanyal","year":"2005","journal-title":"Hepatology"},{"key":"28","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1080\/19490976.2019.1705729","article-title":"Continuous pre- and post-transplant exposure to a disease-associated gut microbiome promotes hyper-acute graft-versus-host disease in wild-type mice.","volume":"1","author":"Hugenholtz","year":"2020","journal-title":"Gut Microbes"},{"key":"29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2015.06.007","article-title":"Stem cell therapies in clinical trials: progress and challenges.","volume":"1","author":"McDonald","year":"2015","journal-title":"Cell Stem Cell"},{"key":"30","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/ni.3002","article-title":"Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications.","volume":"1","author":"Shi","year":"2014","journal-title":"Nat Immunol"},{"key":"31","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/term.2914","article-title":"Mesenchymal stem cells: cell therapy and regeneration potential.","volume":"1","author":"Chaudhry","year":"2019","journal-title":"J Tissue Eng Regen Med"},{"key":"32","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.cellbi.2008.02.002","article-title":"Characterization of mesenchymal stem cells isolated from the human umbilical cord.","volume":"3","author":"Kyurkchiev","year":"2008","journal-title":"Cell Biol Int"},{"key":"33","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1097\/TXD.0000000000000525","article-title":"Human amnion-derived mesenchymal stem cell transplantation ameliorates liver fibrosis in rats.","volume":"1","author":"Sakamoto","year":"2015","journal-title":"Transplant Direct"},{"key":"34","doi-asserted-by":"publisher","first-page":"115101","DOI":"10.1016\/j.taap.2020.115101","article-title":"Diosmin ameliorates inflammation, insulin resistance, and fibrosis in an experimental model of non-alcoholic steatohepatitis in rats.","volume":"40","author":"El-Demerdash","year":"2020","journal-title":"Toxicol Appl Pharmacol"},{"key":"35","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.3748\/wjg.v24.i48.5477","article-title":"Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease.","volume":"2","author":"Kang","year":"2018","journal-title":"World J Gastroenterol"},{"key":"36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/0192623313508481","article-title":"Gut microbiota, low-grade inflammation, and metabolic syndrome.","volume":"4","author":"Gewirtz","year":"2014","journal-title":"Toxicol Pathol"},{"key":"37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.chom.2007.06.010","article-title":"Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of enterobacteriaceae.","volume":"2","author":"Finlay","year":"2007","journal-title":"Cell Host Microbe"},{"key":"38","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","article-title":"Interactions between the intestinal microbiome and liver diseases.","volume":"14","author":"Brenner","year":"2014","journal-title":"Gastroenterology"},{"key":"39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fgene.2015.00081","article-title":"Mucin glycan foraging in the human gut microbiome.","volume":"6","author":"Juge","year":"2015","journal-title":"Front Genet"},{"key":"40","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ijbiomac.2020.01.246","article-title":"Characterization of three novel \u03b2-galactosidases from akkermansia muciniphila involved in mucin degradation.","volume":"14","author":"Deppenmeier","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"41","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","article-title":"Supplementation with akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study.","volume":"2","author":"Hermans","year":"2019","journal-title":"Nat Med"},{"key":"42","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between akkermansia muciniphila and intestinal epithelium controls diet-induced obesity.","volume":"11","author":"Cani","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"43","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3390\/ijms20020308","article-title":"Intestinal microbiota protects against MCD diet-induced steatohepatitis.","volume":"2","author":"Trautwein","year":"2019","journal-title":"Int J Mol Sci"},{"key":"44","doi-asserted-by":"publisher","first-page":"5118","DOI":"10.1021\/acs.jafc.0c01467","article-title":"Modulation of gut microbiota by fucoxanthin during alleviation of obesity in high-fat diet-fed mice.","volume":"6","author":"Wang","year":"2020","journal-title":"J Agric Food Chem"},{"key":"45","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","article-title":"Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.","volume":"1","author":"Fan","year":"2017","journal-title":"Hepatobiliary & Pancreatic Diseases International"},{"key":"46","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s10620-016-4393-x","article-title":"Altered gut microbiota composition and immune response in experimental steatohepatitis mouse models.","volume":"6","author":"Ohnishi","year":"2017","journal-title":"Dig Dis Sci"},{"key":"47","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.aohep.2018.10.003","article-title":"A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma.","volume":"1","author":"Silva","year":"2019","journal-title":"Ann Hepatol"},{"key":"48","doi-asserted-by":"publisher","first-page":"e00692","DOI":"10.1128\/mBio.00692-13","article-title":"The gut microbiome modulates colon tumorigenesis.","volume":"4","author":"Schloss","year":"2013","journal-title":"mBio"},{"key":"49","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1093\/carcin\/bgaa018","article-title":"Parabacteroides distasonis attenuates tumorigenesis, modulates inflammatory markers and promotes intestinal barrier integrity in azoxymethane-treated A\/J mice.","volume":"4","author":"Crott","year":"2020","journal-title":"Carcinogenesis"},{"key":"50","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.celrep.2018.12.028","article-title":"Parabacteroides distasonis alleviates obesity and metabolic dysfunctions via production of succinate and secondary bile acids.","volume":"2","author":"Liu","year":"2019","journal-title":"Cell Rep"},{"key":"51","doi-asserted-by":"publisher","first-page":"13589","DOI":"10.1021\/acs.jafc.9b05833","article-title":"Fuzhuan brick tea attenuates high-fat diet-induced obesity and associated metabolic disorders by shaping gut microbiota.","volume":"6","author":"Zhonghua","year":"2019","journal-title":"J Agric Food Chem"},{"key":"52","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/icb.2015.108","article-title":"Exercise and gut immune function: evidence of alterations in colon immune cell homeostasis and microbiome characteristics with exercise training.","volume":"9","author":"Woods","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"53","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3109\/14653249.2011.563294","article-title":"Minimally manipulated whole human umbilical cord is a rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate.","volume":"1","author":"Introna","year":"2011","journal-title":"Cytotherapy"},{"key":"54","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/jog.13432","article-title":"Comparison of the paracrine activity of mesenchymal stem cells derived from human umbilical cord, amniotic membrane and adipose tissue.","volume":"4","author":"Wielgos","year":"2017","journal-title":"J Obstet Gynaecol Res"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103962","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T06:35:47Z","timestamp":1607322947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,8]]},"references-count":54,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2020,11,15]]}},"alternative-id":["103962","33168782"],"URL":"https:\/\/doi.org\/10.18632\/aging.103962","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,8]]}}}